$37.74
0.04[0.11%]
At close: Apr 23
$37.74
0[0.00%]
After Hours: 4:05PM EDT
Corbus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Corbus Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | CRBP | Q1 | -$4.24 | -$1.52 | — | — | $0.00 | — | — | — | Get Alert |
03/12/2024 | AM | CRBP | Q4 | -$2.61 | -$2.36 | -$1.81 | 23.31% | $0.00 | — | $0.00 | — | Get Alert |
11/07/2023 | AM | CRBP | Q3 | -$2.10 | -$2.06 | -$2.27 | -10.19% | $0.00 | — | $0.00 | — | Get Alert |
08/08/2023 | AM | CRBP | Q2 | -$2.10 | -$3.10 | -$2.05 | 33.87% | $0.00 | — | $0.00 | — | Get Alert |
05/09/2023 | AM | CRBP | Q1 | -$2.40 | -$4.09 | -$4.24 | -3.67% | $0.00 | — | $0.00 | — | Get Alert |
03/07/2023 | AM | CRBP | Q4 | -$2.40 | -$2.10 | -$2.61 | -24.29% | $0.00 | — | $0.00 | — | Get Alert |
11/08/2022 | AM | CRBP | Q3 | -$0.60 | -$1.50 | -$2.10 | -40.00% | $97.32K | $0.00 | $0.00 | — | Get Alert |
08/09/2022 | AM | CRBP | Q2 | -$4.50 | -$1.80 | -$2.10 | -16.67% | $136.56K | $100.00K | $0.00 | -100.00% | Get Alert |
05/10/2022 | AM | CRBP | Q1 | -$4.20 | -$2.40 | -$2.40 | 0.00% | $647.82K | $150.00K | $0.00 | -100.00% | Get Alert |
03/08/2022 | AM | CRBP | Q4 | -$3.00 | -$3.30 | -$2.40 | 27.27% | $658.20K | $350.00K | $0.00 | -100.00% | Get Alert |
11/12/2021 | AM | CRBP | Q3 | -$12.90 | -$3.30 | -$0.60 | 81.82% | $1.23M | $650.00K | $97.32K | -85.03% | Get Alert |
08/12/2021 | AM | CRBP | Q2 | -$15.60 | -$3.60 | -$4.50 | -25.00% | $286.35K | $870.00K | $136.56K | -84.30% | Get Alert |
05/13/2021 | AM | CRBP | Q1 | -$12.90 | -$4.50 | -$4.20 | 6.67% | $1.76M | $960.00K | $647.82K | -32.52% | Get Alert |
03/15/2021 | AM | CRBP | Q4 | -$12.30 | -$7.50 | -$3.00 | 60.00% | $2.57M | $1.49M | $658.20K | -55.83% | Get Alert |
11/10/2020 | AM | CRBP | Q3 | -$9.60 | -$12.60 | -$12.90 | -2.38% | $2.59M | $2.31M | $1.23M | -46.71% | Get Alert |
08/06/2020 | AM | CRBP | Q2 | $0.90 | -$11.70 | -$15.60 | -33.33% | $29.09M | $2.99M | $286.35K | -90.42% | Get Alert |
05/11/2020 | AM | CRBP | Q1 | -$12.90 | -$12.00 | -$12.90 | -7.50% | $1.89M | $2.41M | $1.76M | -26.89% | Get Alert |
03/12/2020 | AM | CRBP | Q4 | -$9.00 | -$10.80 | -$12.30 | -13.89% | $1.93M | $3.68M | $2.57M | -30.05% | Get Alert |
11/07/2019 | AM | CRBP | Q3 | -$7.80 | -$11.40 | -$9.60 | 15.79% | $1.09M | $1.84M | $2.59M | 40.76% | Get Alert |
Corbus Pharmaceuticals (CRBP) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 12, 2024 for Q4.
The Actual EPS was $-1.81, which beat the estimate of $-2.36.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.